Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

- Lupus Arthritis
- Completed

Study Title: Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis

Teva Identifier: LA-LAQ-202

ClinicalTrials.gov Identifier: NCT01085084

Study Status: Completed

Trial Condition(s): Lupus Arthritis

Interventions: Drug: Laquinimod | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 75 Years

Trial Duration: 07/01/2010 - 10/01/2012

Phase: Phase 2

Study Type

Interventional